ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery

Sunday, June 8, 2014

Submitted by

J. Rafael Sadaba

Source

Source Name: Circulation

Source URL: http://www.ncbi.nlm.nih.gov/pubmed/24249720

Author(s)

D'Amario D, Leone AM, Iaconelli A, Luciani N, Gaudino M, Kannappan R, Manchi M, Severino A, Shin SH, Graziani F, Biasillo G, Macchione A, Smaldone C, De Maria GL, Cellini C, Siracusano A, Ottaviani L, Massetti M, Goichberg P, Leri A, Anversa P, Crea F.

In this study, the authors identify a number of markers in cardiac stem cells obtained from 38 patients undergoing coronary artery bypass grafting which appear to predict positive myocardial remodelling at 12 months following surgery